| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/05/2006 | US20060004079 For therapy of cancer and the treatment of bacterial infections |
| 01/05/2006 | US20060004078 N-hydroxyformamidine derivatives |
| 01/05/2006 | US20060004077 Inhibiting class II MHC-mediated activation of T cells; peptidomimetics of given sequence which include a Gpg (guanylpiperidyl glycine) unit; rheumatoid arthritis and/or multiple sclerosis; e.g. Ac-Cha-Gpg-Tic-Nle-NHCH2CH2Ph (Cha=cyclohexylalanine, Tic=3-carboxyisoquinoline, Nle=norleucine) |
| 01/05/2006 | US20060004076 Co-administration of dehydroepiandrosterone (DHEA) congener with pharmaceutically active agents for treating inflammation |
| 01/05/2006 | US20060004075 Substituted aryl amides as IP antagonists |
| 01/05/2006 | US20060004074 e.g. 1-(but-2-ynyl)-2-(3-amino-piperidin-1-yl)-5-(naphth-1-ylmethylaminocarbonyl)-1H-imidazole; dipeptidylpeptidase-IV inhibitor; antidiabetic, anticarcinogenic, antiinflammatory agent; autoimmune, neurodegenerative diseases; |
| 01/05/2006 | US20060004073 Compounds, compositions, and methods |
| 01/05/2006 | US20060004072 Microbiological control in animal processing |
| 01/05/2006 | US20060004071 Comprises sulfur, sodium sulfacetamide, alpha-bisabolol, allantoin, and aloe vera gel |
| 01/05/2006 | US20060004069 Agent for preventing or treating neuropathy |
| 01/05/2006 | US20060004068 Novel hexafluoroisopropanol derivatives |
| 01/05/2006 | US20060004067 N-(2-chloro-6-methylphenyl)-2-(6-(4-(3-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide; high efficiency, high yield process to get 2-aminothiazole-5-carboxamides using halogention reaction; by-products inhibition; anticancer, psoriasis |
| 01/05/2006 | US20060004066 Method for treating ADAMTS-5-associated disease |
| 01/05/2006 | US20060004065 5,5,7,9,13-%-Pentamethyl-16-[1-methyl-2-(2-methyl)-1,3-thiazol-4-yl)-ethenyl]-6,6-dioxo-1-ox-a-6 lambda 6-thia-cyclohexadeca-10,13-dien-2-one; epothilones and derivatives; improved properties; anticarcinogenic, -tumor agents |
| 01/05/2006 | US20060004064 Condensation of substituted diaminobenzene with 2-[4-(1,2,4-oxadiazol-5-on-3-yl)phenylamino]acetic acid; then hydrogenation; carbonylation with an alkylhalogen formate, in the presence of hexyl chloroformate; 4-(benzimidazol-2-ylmethylamino)benzamidine; prevention of deep vein thrombosis |
| 01/05/2006 | US20060004063 Inhibitors of HCV NS5B polymerase |
| 01/05/2006 | US20060004062 Compounds for inhibiting insulin secretion and methods related thereto |
| 01/05/2006 | US20060004061 reacting an anion of 4-amino-3,5-dichloropyridine containing potassium cation with an activated derivative of 3-cyclopropylmethoxy-4-difluoromethoxybenzoic acid in a solvent selected from dimethylformamide or N-methylpyrrolidone; potassium tert-butoxide is used to prepare the amine salt; intermediate |
| 01/05/2006 | US20060004059 Substituted heterocycles for the treatment of diabetes and other diseases |
| 01/05/2006 | US20060004058 Sodium salts of 5-'4-'2-(N-methyl-N-(2-pyridyl) amino) ethoxy!benzyl!thiazolidine -2, 4-dione |
| 01/05/2006 | US20060004057 New compounds |
| 01/05/2006 | US20060004056 Di-aryl-substituted-ethan pyridone pde4 inhibitors |
| 01/05/2006 | US20060004055 Derivative of 5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-N-(piperidine-1-yl)-1H-pyrazole-3-carboxamide, the preparation and therapeutic use thereof |
| 01/05/2006 | US20060004054 Administering 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline before or at the time angioplasty, coronary by-pass grafting or stent implantation |
| 01/05/2006 | US20060004053 Thieno-pyrrole compounds as antagonists of gonadotropin releasing hormone |
| 01/05/2006 | US20060004052 Tricyclic compounds protein kinase inhibitors for enhancing the efficacy of anti-neoplastic agents and radiation therapy |
| 01/05/2006 | US20060004051 Compounds |
| 01/05/2006 | US20060004050 Compositions and methods for the prevention or treatment of pain and other nervous system disorders |
| 01/05/2006 | US20060004049 N-substituted piperidines and their use as pharrmaceuticals |
| 01/05/2006 | US20060004048 Novel biaromatic compounds which activate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 01/05/2006 | US20060004047 Piperidine derivatives as ccr5 inhibitors |
| 01/05/2006 | US20060004046 Such as 6-[2-(2,2-difluoro-2-pyridin-2-yl-ethylamino)-4-oxo-4H-thiazol-(5Z)-ylidenemethyl]-4-ethoxy-quinoline-3-carbonitrile; demonstrate CDK1 antiproliferative activity, useful as anti-cancer agent. |
| 01/05/2006 | US20060004045 Thiazolinone unsubstituted quinolines |
| 01/05/2006 | US20060004044 3-glyoxylamideindoles for treating cancer |
| 01/05/2006 | US20060004043 Indazole compounds and methods of use thereof |
| 01/05/2006 | US20060004042 Formulations comprising selective androgen receptor modulators |
| 01/05/2006 | US20060004041 Compounds for treatment of neurodegenerative diseases |
| 01/05/2006 | US20060004040 Method for the prevention and/or treatment of atherosclerosis |
| 01/05/2006 | US20060004039 Aryl-substituted benzimidazole and imidazopyridine ethers |
| 01/05/2006 | US20060004038 Novel compounds |
| 01/05/2006 | US20060004037 Novel tricyclic compounds and related methods of treatment |
| 01/05/2006 | US20060004036 Sigma-2 receptor agonists and their use in the treatment of HIV infection |
| 01/05/2006 | US20060004035 System for identification of a pharmaceutical product |
| 01/05/2006 | US20060004034 Treating conditions associated with the nociceptin/ORL1 receptor system, e.g. pain, drug withdrawal, anxiety, muscle relaxants, anxiolytic agents; e.g. 1,1-[3-dimethylamino-3-(pyridin-2-yl)pentamethylene]-3,4-dihydro-1H-2,9-diazafluorene |
| 01/05/2006 | US20060004033 Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation |
| 01/05/2006 | US20060004032 GTPase inhibitors and methods of use |
| 01/05/2006 | US20060004031 Process for preparing 1-methoxymethyl-5,5-diphenylbarbituric acid |
| 01/05/2006 | US20060004030 Asthma, antiallergens; rheumatoid arthritis and atherosclerosis; anticarcinogenic agents; 2-(Benzylthio)-6-{[(1R)-2-hydroxy-1-methylethyl]amino}-4-pyrimidinol |
| 01/05/2006 | US20060004029 Nitrogen-containing aromatic derivatives |
| 01/05/2006 | US20060004028 Novel PARP inhibitor |
| 01/05/2006 | US20060004027 Drying process for preparing crystalline solid famciclovir |
| 01/05/2006 | US20060004026 Compositions for ameliorating attention-deficient/hyperactivity disorder |
| 01/05/2006 | US20060004025 Arylamine substututed bicyclic heteroaromatic compounds as p38 kinase inhibitors |
| 01/05/2006 | US20060004024 Reacting 2,4-difluorophenyl (4-piperidinyl) methanone oxime hydrochloride and 3-(2-haloethyl)-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one in an aqueous alkali solution: high yeild when alkali hydroxide concentration is in the range of 20 to 40% |
| 01/05/2006 | US20060004023 Treatment for attention-deficit hyperactivity disorder |
| 01/05/2006 | US20060004022 4-, 5-, 6- And 7-indole derivatives useful for the treatment of CNS disorders |
| 01/05/2006 | US20060004021 Ethyl 4-{[2-(3-chlorophenyl)-2H-tetrazol-5-yl]methyl}piperazine-1-carboxylate; gastrointestinal disorders, chronic and acute pain, psychiatric and neurological disorders; obesity |
| 01/05/2006 | US20060004020 Pyrrolidine derivatives as oxytocin antagonists |
| 01/05/2006 | US20060004019 Steroid sparing agents and methods of using same |
| 01/05/2006 | US20060004018 To treat inflammatory diseases, immune diseases and cancer; N-[(1R,3S)-3-isopropyl-3-9{4-[3-(trifluoromethyl)phenyl]piperazin-1-yl}carbonyl)cyclopentyl]tetrahydro-2H-pyran-4-amine; side effect reduction; improved long term safety profile; oral administration; half life |
| 01/05/2006 | US20060004017 Quinazoline derivatives as angiogenesis inhibitors |
| 01/05/2006 | US20060004016 Administering (-)3-((S)-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)(3-thienyl)methyl)phenol or a pharmaceutically acceptable salt thereof for reducing ischemic damage |
| 01/05/2006 | US20060004015 Fibrotic disorders; disorders characterized by harmful buildup of collagen and/or by excessive lysyl oxidase enzymatic activity |
| 01/05/2006 | US20060004014 2-Benzylaminodihydropteridinones, process for their manufacture and use thereof as medicaments |
| 01/05/2006 | US20060004013 Cinnamide compound |
| 01/05/2006 | US20060004012 antidiabetic agents for treatment of type II diabetes |
| 01/05/2006 | US20060004011 Indolyl pyrazinone derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| 01/05/2006 | US20060004010 Ccr4 antagonist and medical use thereof |
| 01/05/2006 | US20060004009 Ethylenediamine derivatives |
| 01/05/2006 | US20060004008 Topoisomerase inhibitors; useful as antibacterial, antifungal agents; cancer; structure is based on substituted benzo(i)phenanthridine ring where the ring carbon atoms at position 5 and 11 are optionally replaced by nitrogen |
| 01/05/2006 | US20060004007 Pyrrolotriazine inhibitors of kinases |
| 01/05/2006 | US20060004006 Pyrrolotriazine kinase inhibitors |
| 01/05/2006 | US20060004005 Triazines derivatives as cell adhesion inhibitors |
| 01/05/2006 | US20060004004 Novel gamma secretase inhibitors |
| 01/05/2006 | US20060004003 e.g. 1-Ethyl-4-(5-methyl-3-pyridyl)-6-phenyl-1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid; phosphodiesterase (PDE)-IV inhibitor or tumor necrosis factor (TNF)- alpha antagonist; autoimmune diseases, antidepressant, anxiolytic agent; polychondritis, scleroderma, fibrosis, arthritis, Alzheimer's disease |
| 01/05/2006 | US20060004002 Small molecule thienopyrimidine-based protein tyrosine kinase inhibitors |
| 01/05/2006 | US20060004001 Specific binding is extremely high; low toxicity; high degree of activity; 2-(5-m-Tolyl-thiazol-2-yl )-7,8-dihydro-6H-quinolin-5-one, acute and/or chronic neurological disorders |
| 01/05/2006 | US20060004000 N-aryl-5-substituted-3-yl-1H-indazole-3-carboxamides; amidation of the 1-protected-1H-indazole-3-carboxylic acid, deblocking; hypotensive agents |
| 01/05/2006 | US20060003999 reduction of 4-methoxy-5-(3-morpholinopropoxy)-2-nitrobenzonitrile to give 2-amino-4-methoxy-5-(3-morpholinopropoxy)benzonitrile, hydration of intermediated to form 2-amino-4-methoxy-5-(3-morpholinopropoxy)benzamide; cyclization |
| 01/05/2006 | US20060003998 2-(2-Methoxy-phenyl)-1-morpholin-2-yl-1-phenyl-ethanol hydrochloride; selective inhibitors of the reuptake of norepinephrine; in membrane cells of central nervous system; anxiolitic agent, cognition activator, psycological disorder |
| 01/05/2006 | US20060003997 Substituted benzo[e] [1,4] oxazino [3,2-g] isoindole compounds |
| 01/05/2006 | US20060003996 Intralesional treatment of psoriasis |
| 01/05/2006 | US20060003995 Stereospecific anxiolytic and anticonvulsant agents with reduced muscle-relaxant, sedative-hypnotic and ataxic effects |
| 01/05/2006 | US20060003994 Pyrrolo[2,1-c][1,4]benzodiazepine-napthalimide conjugates linked through piperazine moiety and process for preparation thereof |
| 01/05/2006 | US20060003993 Benzotriazepnes as gastrin and cholecystokinin receptor ligands |
| 01/05/2006 | US20060003992 New drug combinations |
| 01/05/2006 | US20060003991 Compounds |
| 01/05/2006 | US20060003990 Substituted azepine derivatives as serotonin receptor modulators |
| 01/05/2006 | US20060003989 Compositions and methods using acetylcholinesterase (ACE) inhibitors to treat central nervous system (CNS) disorders in mammals |
| 01/05/2006 | US20060003988 Compounds capable of inhibiting immunocyte-related allergic immune reactions |
| 01/05/2006 | US20060003987 Compounds and their uses |
| 01/05/2006 | US20060003986 Such as 4-(4-Methoxy-7-morpholin-4-yl-benzothiazol-2-ylcarbamoyl)-piperidine-1-carboxylic acid tert-butyl ester; for prevention of illnesses based on the modulation of the adenosine system, such as Alzheimer's disease, Parkinson's disease, neuroprotection, schizophrenia, anxiety, pain |
| 01/05/2006 | US20060003985 Enhancement of sleep with t-type calcium channel antagonists |
| 01/05/2006 | US20060003984 Monobactam compositions and methods of use thereof |
| 01/05/2006 | US20060003983 Photosensitizer and method for production thereof |
| 01/05/2006 | US20060003982 Pyridyl-substituted porphyrin compounds and methods of use thereof |
| 01/05/2006 | US20060003981 Combinations of chromium or vanadium with antidiabetics for glucose metabolism disorders |
| 01/05/2006 | US20060003980 Cobalt(II) complexes as protein tyrosine kinase inhibitors |
| 01/05/2006 | US20060003979 Topical compositions of cyclic amides as immunotherapeutic agents |
| 01/05/2006 | US20060003978 beta-secretase inhibitors; to reduce A beta peptide formation; to reduce amyloid beta deposits or plaques; 12-[2-(3-Ethyl-benzylamino)-1-hydroxy-ethyl]-16-fluoro-2-oxa-8,11-diaza-bicyclo[12.3.1]octadeca-1(17),14(18),15-triene-7,10-dione |